Bren Higgins
Analyst · Cowen and Company. Your line is now open
Thanks, Rick and good afternoon. Revenue for Q2 was in the upper half of the range of guidance at $676 million and non-GAAP earnings per share finished above the guided range for the quarter at $0.68, driven by stronger than expected gross margins in the quarter and good execution of cost management, fully diluted GAAP earnings per share in Q2 was $0.12. The GAAP earnings per share in Q2 included $0.53 of charges related to the leveraged recapitalization transaction, which we completed in Q2 and $0.03 of restructuring and acquisition related charges, net of the income tax effect on these adjustments. My comments on the quarter will be focused on the non-GAAP results, which exclude these adjustments. A detailed reconciliation of GAAP to non-GAAP earnings per share can be found in the press release and supplemental materials posted on our Website prior to this earnings call. New orders in Q2 were $865 million above the midpoint of guidance of $700 million to $900 million for the quarter. We continue to experience a high degree of variability in order timing and delivery day commitments from our customers. We believe this is the new normal for our industry, with our top five customers accounting for approximately 75% of demand today and often with one or two customers accounting for a significant portion of order and shipment volume in a given quarter. With each customer having their unique timeline for executing their technology, investment and capacity expansion plans and with shorter product delivery lead times becoming normal in our industry, forecasting accuracy of bookings within a 12 week window has clearly become even more of a challenge. With that, though December orders and shipments were strong, the near term shift in customer demand requirements that Rick mentioned have resulted in certain shipments which were originally slated for the March and June quarters moving into the second half of calendar 2015. We see this is largely a timing issue and our optimism for calendar 2015 to be a growth year for KLA-Tencor is high. Our internal shipments forecast for calendar 2015 is consistent with business levels that would support revenue growth for KLA-Tencor, in line with the overall industry growth rates and what is expected to be another year of strong CapEx investment, with shipment volumes roughly balanced across the first and second half for the year. Regarding customer segment commentary for the second quarter, combined foundry and logic customer demand was 56% of new orders in Q2, and slightly below our expectations for the quarter due to some marginal weakness at the leading edge. As I mentioned, we believe the near term volatility in foundry and logic is largely a timing issue and a function of a variety of factors including customer concentration and yield issues as well as shifting capacity requirements at the leading edge for 14 and 16 nanometer and the timing of early development activity for 10 nanometer. Memory bookings were a record in Q2, finishing at 44% of new system orders in a period with upside from DRAM. We expect memory demand as a percent of total system orders in calendar year 2015 to be on par with our calendar 2014 result, with investment focused on technology upgrades in DRAM and our capacity additions of plainer device architectures in NAND and 3D NAND. Investment by our customers at 20 nanometer and below constituted roughly 69% of the orders we received in the December quarter. Turning now to the distribution of orders by product group; wafer inspection was approximately 47%, reticle inspection was 11%, metrology was approximately 20%, service was 20%, storage, high brightness LED and other non-semi was approximately 2%. Total shipments in Q2 were $766 million, up 40% sequentially from September. We expect shipping growth again in Q3 to a midpoint of approximately $785 million in the quarter. Given current shipment backlog, we expect shipment levels to remaining at a high level with first year calendar 2015 shipments expected to grow compared with the second half of 2014. In total we ended the year with just over 1.3 billion of total backlog, comprised of 1.1 billion of shipment backlog or orders that have not yet shipped to customers and expect to ship over the next six to nine months. Total backlog includes $262 million of revenue backlog of products that have been shipment and invoiced, but have not yet have been accepted by customers. Turning to the income statement, revenue for the quarter was $676 million above the midpoint of the guided range and up 5% compared with Q1. Gross margin was 58.5%, an increase of nearly 3% from September and significantly above the guided range for the quarter. Our gross margin significantly exceeded guidance for the quarter due to a favorable mix of products and services and better than expected manufacturing efficiencies due to output levels and favorable foreign exchange impact in our off shore factories. We expect gross margin to be in the range of 56.5% and 57.5% in the March quarter as the benefit of higher revenue volume is offset by a less favorable product mix compared to the December quarter. The shipment dynamics related to today's operating environment have also added additional volatility to our gross margins. Over time our gross margin performance should continue to reflect our differentiated business model, which is fueled by 50% to 70% incremental gross margins. Operating expenses were $231 million, down from $240 million in Q1 and below the guided range of $236 million to $238 million for the quarter, as we saw the benefit of a heightened focus on cost management. Over the past few years we have made critical investments in R&D and customer application support, advancing the product roadmap for flagship products such as Broadband Plasma and latest scattering wafer inspection technologies and the Archer platform in overlay metrology. We’ve also made investments in new opportunities for growth, such as the 5D patterning control solution. We believe there are additional opportunities to continue to meet customer requirements and sustain our market leadership, while driving better cost efficiencies throughout our organization. Looking ahead, we are modeling operating expenses of approximately $227 million to $229 million in the March quarter and expect operating expense level to decline over the course of the calendar year to about $220 million per quarter. Other income and expense for the quarter was a net expense of $29 million, reflecting the impact of the debt on the balance sheet resulting from our leverage tree capitalization. We expect OAE to be a net expense in March of approximately $30 million. The tax rate was 16.4% in Q2, lower than the 23% revised guidance rate for the December quarter, principally driven by the reinstatement of the R&D tax credit in the U.S. Going forward, you should continue to use a long term planning rate of 22% for modeling purposes. At the 22% guided tax rate, earnings per share would have been $0.64 in Q2. Net income was $113 million or $0.68 per fully diluted share. Turning to the balance sheet, cash and investments ended the quarter at $2.4 billion, a decrease of 576 million compared with September. This reflects the impact of the leverage recapitalization transaction we completed in the December quarter. In conjunction with this transaction, we issued an aggregate amount of 2.5 billion of senior notes with various maturities with a blended interest rate of 4.28%. We also entered into a $1.25 billion five year senior unsecured revolving credit and term loan facility. This credit facility consists of $750 million of amortizing term loans and commitments for an unfunded revolving credit facility of $500 million. The interest rate on the $750 million credit facility is 1.49% based on current rates. With proceeds from the leverage recapitalization, we paid a special cash dividend of $16.50 per share for a total amount of $2.76 billion. Concurrent with our leverage recapitalization, we also announced that the Board of Directors has authorized an expansion of our existing $1 billion share repurchase authorization announced in July by an additional $250 million. In quarter, we repurchased 2.1 million shares of stock at an average price of $69.94. As of December 31, we had approximately 14.8 million shares available for repurchase under our current authorization. We plan to execute these share repurchases over the next 12 to 18 months. In addition to the $16.50 special cash dividend in December, we paid a regular dividend of $82 million or $0.50 per share in the quarter. Cash from operations was $11 million in the quarter, down $24 million sequentially, largely due to the higher account receivable associated with the ramp in shipments in the quarter and monthly shipment linearity. And lastly, fully diluted shares ended the quarter at $167 million. In conclusion to reiterate, our guidance for the March quarter is, new orders are expected to be in the range of $500 million to $700 million, revenue is expected in the range of $685 million to $765 million, with non-GAAP earnings per share in the range of $0.63 to $0.87 per share. This concludes our remarks on the quarter. I’ll turn the call back over to Ed to begin the Q&A.